Effect of a phase 2 cardiac rehabilitation program on obese and non-obese patients with stable coronary artery disease

The Egyptian Heart Journal

Table 2 Comparing clinical, laboratory, and echocardiographic variables at the end of the program

Variable	Non-obese patients (n = 58)	Obese patients (n = 62)	p value
Clinical characteristics at the end of the program
BMI, kg/m²	26.77 ± 1.77	31.97 ± 3.47	< 0.001
Systolic BP, mmHg	117.41 ± 7.27	120.81 ± 11.19	0.172
Diastolic BP, mmHg	76.55 ± 5.99	76.77 ± 7.91	0.903
METs achieved	11.89 ± 2.43	9.82 ± 2.59	0.002
Laboratory tests at the end of the program
Total cholesterol, mg/dl	138.41 ± 29.53	151.13 ± 25.95	0.081
LDL-C, mg/dl	78.37 ± 27.34	95.86 ± 26.45	0.015
HDL-C, mg/dl	44.00 ± 8.46	43.74 ± 7.95	0.903
Triglycerides, mg/dl	122.49 ± 63.73	129.48 ± 48.44	0.633
Fasting blood sugar, mg/dl	95.62 ± 22.24	101.87 ± 23.01	0.290
Echocardiographic parameters at the end of the program
LVEDD, mm	52.17 ± 4.51	52.35 ± 4.66	0.878
LVESD, mm	36.10 ± 5.09	35.84 ± 4.75	0.836
LVEF, %	56.83 ± 7.83	57.35 ± 8.95	0.809

Continuous variables are expressed as mean and standard deviation whereas categorical variables are expressed as number (percentage)
BMI body mass index, BP blood pressure, METs metabolic equivalent of tasks, LDL-C low-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol, LVEDD left ventricular end-diastolic diameter, LVESD left ventricular end-systolic diameter, LVEF left ventricular ejection fraction